Concepedia
Statistics
Publications
3
Citations
79
H-Index
Active since
2019
Affiliations
University of California San Diego(Current)
Center for Cancer and Blood Disorders
Rady Children's Hospital-San Diego
Nikki Phanhthilath is an author at University of California San Diego specializing in medicine, cancer pharmacology, and oncology.
Publications per year
2019–2020
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways
Divya Subramonian, Nikki Phanhthilath, Hannah Rinehardt et al. · British Journal of Cancer · 2020 · 54 citations · Full text
Medicine, Oncology, Pharmacology +12
Mechanisms of Efficacy of the FGFR1–3 Inhibitor AZD4547 in Pediatric Solid Tumor Models
Nikki Phanhthilath, Sara Hakim, Catherine K. Su et al. · Investigational New Drugs · 2020 · 14 citations
Medicine, Oncology, Pharmacology +10
The multikinase inhibitor RXDX-105 is effective against neuroblastoma<i>in vitro</i>and<i>in vivo</i>
Sean Flynn, Jacqueline Lesperance, Andrew Macias et al. · Oncotarget · 2019 · 11 citations · Full text
1–3 of 3